Standard BioTools Inc.

NASDAQ: LAB · Real-Time Price · USD
1.22
0.00 (0.00%)
At close: Aug 15, 2025, 11:54 AM

Standard BioTools Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-33.46M -26.03M -34.07M -26.94M -45.72M -32.16M -19.78M -21M -17.04M -16.84M -20.84M -29.43M -63.54M -76.29M -9.43M -13.84M -17.14M -18.82M
Depreciation & Amortization
-2.46M 4.17M -8.56M 3.86M 3.86M 5.19M 3.91M 3.99M 3.63M 3.66M 3.62M 3.6M 3.83M 3.97M 3.88M 3.87M 3.9M 3.92M
Stock-Based Compensation
6.39M 9.01M 7.47M 5.92M 6.73M 11.61M 3.48M 3.39M 3.11M 3.15M 1.68M 4.49M 4.66M 4.04M 4.36M 4.32M 3.74M 3.68M
Other Working Capital
9.18M -9.18M -3.62M -29.15M -1.49M -6.57M 1.61M 3.28M 1.98M 1.2M -2.59M 1.15M -5.67M 1.81M -4.74M -5.97M 139K -12.59M
Other Non-Cash Items
-6.74M -1.83M 13.09M -21K 107K -24.63M 14.45M 131K 352K 240K 203K 3.58M -11.22M 11.82M 1.07M 576K 1.18M 610K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -14.51M 391K 222K n/a 742K -742K 44.13M 37.79M -1.52M 297K 933K 315K
Change in Working Capital
15.6M -15.6M 8.02M -10.69M -4.03M -22.5M -1.61M 1.69M 397K 1.31M -4.58M -6.12M -7.86M 3.07M -6.89M -4.42M -6.34M -2.28M
Operating Cash Flow
-20.67M -30.28M -14.06M -27.87M -39.05M -62.48M -14.06M -11.41M -9.33M -8.48M -19.18M -24.61M -29.99M -15.59M -7M -9.49M -14.66M -12.9M
Capital Expenditures
-1.89M -5.05M -3.38M -2.25M -1.94M -781K -78K -905K -838K -1.01M -755K -1.26M -938K -868K -463K -1.71M -4.17M -6.92M
Cash Acquisitions
n/a n/a -1.39M n/a n/a 280.03M 13.04M n/a n/a -44.16M n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-18.61M -32.32M -29.51M -78.63M -74.81M -73.18M -39.04M -49.02M n/a -6.84M n/a n/a -137.3M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
48M 52M 60M 50M 127M 112M 26M n/a 40.96M 51M 41M 12M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a -13.04M n/a 40.96M 44.16M 41M 12M -137.3M n/a -682K n/a n/a 2M
Investing Cash Flow
27.5M 14.63M 25.73M -30.88M 50.26M 318.07M -13.12M -49.93M 40.13M 43.15M 40.24M 10.74M -138.24M -868K -1.15M -1.71M -4.17M -4.92M
Debt Repayment
n/a n/a -55M n/a n/a -8.19M -1.25M -833K n/a n/a n/a n/a n/a 18.16M 6.84M 10M n/a -501K
Common Stock Repurchased
n/a -46K -45K -70K -29.44M -11.05M -174K -399K -2.38M -2.47M -563K -102K 8K -87K -98K -144K -1.03M -525K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
108K n/a -38.98M -70K -327K -473K 421K 68K -35K -92K -270K -4K 212.96M -87K 557K -35K -133K -525K
Financial Cash Flow
108K -46K -54.52M -2K -28.36M -19.73M -1M -1.16M -2.08M -2.56M -270K -5K 212.96M 18.07M 7.3M 9.82M -133K -1.03M
Net Cash Flow
7.73M -15.35M -43.12M -59.16M -17.25M 235.35M -27.95M -62.65M 28.64M 32.13M 21.11M -14.16M 44.38M 1.53M -858K -1.55M -18.88M -18.78M
Free Cash Flow
-22.55M -35.34M -17.44M -30.12M -40.99M -63.26M -14.14M -12.32M -10.17M -9.49M -19.94M -25.88M -30.93M -16.46M -7.46M -11.2M -18.84M -19.82M